SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of CreXus Investment Corp. In Connection With The Sale Of The Company To Annaly Capital Management, Inc.

Levi & Korsinsky is investigating the Board of Directors of CreXus Investment Corp. (“CreXus” or the “Company”) (NYSE: CXS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Annaly Capital Management, Inc. (“Annaly”) (NYSE: NLY).

Click here to learn more about the investigation, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, CreXus shareholders will receive $12.50 for each share of CreXus stock they own. The transaction has a total approximate value of $839 million. Annaly already holds a 12.4% stake in CreXus. The investigation concerns whether the CreXus Board of Directors breached their fiduciary duties to CreXus stockholders by failing to adequately shop the Company before entering into this transaction and whether Annaly is underpaying for CreXus shares, thus unlawfully harming CreXus stockholders. Annaly’s wholly owned subsidiary, Fixed Income Discount Advisory Co. (FIDAC) manages CreXus, and two of FIDAC’s employees are on CreXus’ board of directors.

If you own common stock in CreXus and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit

Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

If you liked this article you might like

3 Buy-Rated Dividend Stocks: AI, CXS, CLCT

4 Buy-Rated Dividend Stocks: AI, CXS, LGCY, CMLP

4 Buy-Rated Dividend Stocks: CXS, BKCC, CMLP, APSA

4 Buy-Rated Dividend Stocks: CXS, BKCC, GNI, EXLP

3 Buy-Rated Dividend Stocks: SPH, CXS, TCRD